Bio-Path Holdings Announces Director Changes and New CFO
Ticker: BPTH · Form: 8-K · Filed: Jun 24, 2025 · CIK: 1133818
| Field | Detail |
|---|---|
| Company | Bio-Path Holdings, Inc. (BPTH) |
| Form Type | 8-K |
| Filed Date | Jun 24, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, officer-appointment, board-composition
Related Tickers: BPTH
TL;DR
Bio-Path Holdings shakes up board, names new CFO.
AI Summary
Bio-Path Holdings, Inc. announced on June 20, 2025, a series of significant corporate actions. These include the departure of Director Dr. Michael W. R. Smith, the election of new Directors Dr. David M. E. Chew and Mr. David M. E. Chew, and the appointment of Mr. Christopher J. O'Brien as Chief Financial Officer. The company also disclosed compensatory arrangements for its officers.
Why It Matters
These changes in leadership and board composition can signal shifts in strategic direction or operational focus for Bio-Path Holdings, potentially impacting its future performance and investor outlook.
Risk Assessment
Risk Level: medium — Changes in key leadership and board members can introduce uncertainty regarding future strategy and execution.
Key Players & Entities
- Bio-Path Holdings, Inc. (company) — Registrant
- Dr. Michael W. R. Smith (person) — Departing Director
- Dr. David M. E. Chew (person) — Newly Elected Director
- Mr. David M. E. Chew (person) — Newly Elected Director
- Mr. Christopher J. O'Brien (person) — Appointed Chief Financial Officer
FAQ
Who has departed from Bio-Path Holdings' board of directors?
Dr. Michael W. R. Smith has departed from the board of directors.
Who has been elected as new directors to the board?
Dr. David M. E. Chew and Mr. David M. E. Chew have been elected as new directors.
Who has been appointed as the new Chief Financial Officer?
Mr. Christopher J. O'Brien has been appointed as the new Chief Financial Officer.
What is the reporting date for this 8-K filing?
The earliest event reported is dated June 20, 2025.
What are the primary items covered in this 8-K filing?
The filing covers the departure of directors, election of directors, appointment of officers, and compensatory arrangements of certain officers.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 24, 2025 by Dr. Michael W. R. Smith regarding BIO-PATH HOLDINGS, INC. (BPTH).